Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling

This study has been completed.
Information provided by:
Graceway Pharmaceuticals, LLC Identifier:
First received: June 16, 2005
Last updated: February 16, 2007
Last verified: January 2006
Skin chronically exposed to the sun may become damaged and then develop wrinkles and/or uneven skin color. The purpose of this research study is to evaluate a newly developed scale (grading tool) that rates wrinkles and uneven skin color. This newly developed scale will be used in future topical drug studies to measure these changes in the skin.

Skin Wrinkling

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: A Multicenter Study to Validate Cosmetic Outcome Scales Used to Assess Irregular Skin Pigmentation and Wrinkling

Resource links provided by NLM:

Further study details as provided by Graceway Pharmaceuticals, LLC:

Estimated Enrollment: 48
Study Start Date: June 2005

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • At least 18 years of age

Exclusion Criteria:

  • Have any disease of the skin, condition, or cosmetics around the eyes that may cause difficulty with the skin assessment using the scale to rate wrinkles and uneven skin color
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00114673

United States, Massachusetts
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Graceway Pharmaceuticals, LLC
Principal Investigator: Tania J Phillips, M.D. Boston University
  More Information Identifier: NCT00114673     History of Changes
Other Study ID Numbers: 1521-R850 
Study First Received: June 16, 2005
Last Updated: February 16, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Graceway Pharmaceuticals, LLC:
Uneven skin color
Wrinkles and uneven skin color in the area around the eyes processed this record on October 21, 2016